A Science and Technology Blog
“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered early on during COVID, Virafin will help patients recover faster…
A ribonucleoside analog (β-D-N4-hydroxycytidine or NHC) that was previously shown to be effective against influenza and Ebola is also potent against coronaviruses, including the novel coronavirus. The prodrug of NHC…
Treating severe COVID-19 patients with the antiviral drug remdesivir does not quicken recovery, the first randomised, placebo-controlled, double-blind trial found. Although not statistically significant, those treated with the drug within…
One of the inhibitors that showed good antiviral activity against other coronaviruses was modified for enhanced antiviral activity. The inhibitor was found in the lungs even after 24 hours when…
